样式: 排序: IF: - GO 导出 标记为已读
-
Neuromodulations in Psychiatric Disorders: Emerging Lines of Definition. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-14 Xiaolei Liu,Hongxing Wang
-
Karl Rickels Centenarian: Celebration of a Clinician-Scientist. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-13 Richard Balon
-
The Power of a Good Word: Enhancing the Efficacy of Analgesics in Clinical Settings. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-04 Roi Treister,Vered Cohen,Limor Issa,Karine Beiruti Wiegler,Alexander Izakson,Mariana Agostinho
INTRODUCTION Communication between medical staff and patients about treatment efficacy elicits expectations of benefit and improves treatment outcomes. While demonstrated in multiple studies via different research methodologies, uniform communication protocols have not been adopted in clinical practice. Here, we summarize the results of two sister studies aimed at bridging this gap. METHODS Women undergoing
-
Reconsidering Persistent Somatic Symptoms: A Transdiagnostic and Transsymptomatic Approach. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-29 Bernd Löwe,Stephan Zipfel,Omer van den Bergh,Peter Henningsen
-
Developing and Testing Complex Interventions in Psychosomatic Medicine. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-25 Christopher Burton
-
Efficacy of a Standalone Smartphone Application to Treat Postnatal Depression: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-23 Pedro F Zuccolo,André R Brunoni,Tatiane Borja,Alicia Matijasevich,Guilherme V Polanczyk,Daniel Fatori
INTRODUCTION Smartphone app interventions based on cognitive-behavioral therapy (CBT) are promising scalable alternatives for treating mental disorders, but the evidence of their efficacy for postpartum depression is limited. We assessed the efficacy of Motherly, a standalone CBT-based smartphone app, in reducing symptoms of postpartum depression. METHODS Women aged 18-40 with symptoms of postpartum
-
Challenges for the Moral Injury Construct. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-23 Richard A Bryant
-
Evolution of Psychotropic Medication Prescription in Young People: Reflection from the Quebec Experience. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-22 Joël Monzée
-
Inference-Based Cognitive Behavioral Therapy versus Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder: A Multisite Randomized Controlled Non-Inferiority Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-18 Nadja Wolf,Patricia van Oppen,Adriaan W Hoogendoorn,Odile A van den Heuvel,Harold J G M van Megen,Aniek Broekhuizen,Mirjam Kampman,Daniëlle C Cath,Koen R J Schruers,Saskia M van Es,Tamara Opdam,Anton J L M van Balkom,Henny A D Visser
INTRODUCTION Although cognitive behavioral therapy (CBT) effectively treats obsessive-compulsive disorder (OCD), many patients refuse CBT or drop out prematurely, partly because of anxiety regarding exposure and response prevention (ERP) exercises. Inference-based cognitive behavioral therapy (I-CBT) focuses on correcting distorted inferential thinking patterns, enhancing reality-based reasoning, and
-
Study of Rates and Factors Associated to Psychosomatic Syndromes Assessed Using the Diagnostic Criteria for Psychosomatic Research across Different Clinical Settings. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-17 Wei Xu,Wenhao Jiang,Rongjing Ding,Hong Tao,Yanyong Wang,Yanping Tang,Dongfeng Liang,Yuping Wang,Mingwei Wang,Bingwei Chen,Youyong Kong,Lei Liu,Yingying Yue,Liangliang Tan,Lu Yu,Fiammetta Cosci,Yonggui Yuan,
INTRODUCTION Diagnostic Criteria for Psychosomatic Research (DCPR) serve as an instrument for identifying and classifying specific psychosomatic syndromes that are not adequately encompassed in standard nosography. The present study aimed at measuring the prevalence of DCPR syndromes in different clinical settings and exploring factors associated to such diagnoses. METHODS A cross-sectional and nationwide
-
The importance of the appropriate use of terms related to body ownership in research using avatars. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-14 Monika Kisielewska,Beata Mirucka
-
Reply to Kisielewska and Mirucka: The Crucial Aspect of Ownership Illusions Is Their Strength, Not the Method to Induce Them. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-14 Simone C Behrens,Katrin E Giel,Stephan Zipfel
-
Innovative Strategies in Evaluation and Treatment of Burnout in Medical Workers. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-11 Jenny Guidi,Giovanni A Fava
-
Enhancing Conceptual Clarity regarding the Construct of Moral Injury. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-10-07 Sheila Frankfurt O'Brien,Isabelle Baptista,Philip R Szeszko
BACKGROUND The construct of "moral injury" is used widely in the research literature and media to broadly describe the impact of events involving perceived violations of one's sense of right and wrong (herein referred to as "potentially morally injurious events" [PMIEs]). SUMMARY In this theoretical review, we provided a brief overview of the "moral injury" construct and its limitations including the
-
The Role of Online Well-Being Therapy in Overcoming Allostatic Overload in Medical Workers: A Pilot Randomized Controlled Study. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-23 Xiaolei Liu,Penghui Song,Lu Yin,Kun Wang,Boheng Zhu,Xiaomin Huang,Yanyan Niu,Haixia Leng,Qing Xue,Mao Peng,Baoquan Min,Fangfang Shangguan,Peiran Zhang,Wenfeng Zhao,Huang Wang,Jing Lv,Mei Yang,Ping Wang,Dongning Li,Xiaoling Gao,Kun Feng,Keming Yun,Fiammetta Cosci,Hongxing Wang
INTRODUCTION Stress may lead to allostatic overload. Well-being therapy (WBT) might mitigate it by enhancing psychological well-being and protecting from psychological symptoms. Since no reports are available on the use of WBT in allostatic overload, we evaluated online WBT effects in reducing allostatic overload in medical workers during the coronavirus pandemic. METHODS Sixty-six participants with
-
Should Loneliness Be a Treatment Target? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-16 Tobias Krieger,Noëmi Seewer
-
Childhood Trauma and the Immune System: A Complex Interaction That Can Lead to Biopsychosocial Pathogenesis. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-12 Laiana A Quagliato,Antonio E Nardi
-
Rise in Persistent Somatic Syndromes: A Relationship with Systemic Changes in Healthcare? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-11 Tahir Jokinen
-
Response to Philips et al.: Several Fundamental Misconceptions about Evidence-Based Practice. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-09-05 Sophie Juul,Janus Christian Jakobsen,Emilie Hestbaek,Caroline Barkholt Kamp,Markus Harboe Olsen,Marie Rishede,Frederik Weischer Frandsen,Sune Bo,Stig Poulsen,Per Sørensen,Anthony Bateman,Sebastian Simonsen
-
Nocebo and Placebo Effects and Their Implications in Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-08-30 Winfried Rief,Marcel Wilhelm
-
Reducing Distress from Auditory Verbal Hallucinations: A Multicenter, Parallel, Single-Blind, Randomized Controlled Feasibility Trial of Relating Therapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-08-21 Tania Marie Lincoln,Björn Schlier,Rebecca Müller,Mark Hayward,Anne-Katharina Fladung,Niklas Bergmann,Kerem Böge,Jürgen Gallinat,Candelaria Mahlke,Uwe Gonther,Thomas Lang,Cornelia Exner,Anika Buchholz,Katharina Stahlmann,Antonia Zapf,Geraldine Rauch,Matthias Pillny
INTRODUCTION There is a significant demand for interventions that reduce distress related to auditory verbal hallucinations (AVHs). AVH distress is associated with the way voice hearers relate with AVHs. We aimed to establish the feasibility of a randomized controlled trial to demonstrate that adding "Relating Therapy" (RT) to treatment as usual (TAU) is superior to TAU in reducing AVH distress. METHODS
-
Flaws in the Design of a Randomized Controlled Trial Comparing Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-31 Björn Philips,Falk Leichsenring,Henning Jordet,Sigmund Karterud
-
Adverse Events of Psychological Interventions: Definitions, Assessment, Current State of the Research and Implications for Research and Clinical Practice. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-29 Jan Philipp Klein,Alexander Rozental,Svenja Sürig,Steffen Moritz
BACKGROUND The effectiveness of psychological interventions is undisputed. But while in other fields of health care the safety of interventions is studied alongside effectiveness, adverse events (AEs) have only recently been assessed in clinical studies of psychological interventions. This critical review summarizes the definition, assessment and current research status of AEs of psychological interventions
-
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-23 Fiammetta Cosci,Virginie-Anne Chouinard,Guy Chouinard
INTRODUCTION Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may cause withdrawal at dose decrease, discontinuation, or switch. Current diagnostic methods (e.g., DSM) do not take such phenomenon into account. Using a new nosographic classification of withdrawal syndromes due to SSRI/SNRI decrease or discontinuation [by Psychother Psychosom. 2015;84(2):63-71]
-
The Clinical Meaning of Withdrawal with Antidepressant Drugs. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-18 Giovanni A Fava
-
The Effectiveness of Dialectical Behavior Therapy Compared to Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-07-10 Nele Assmann,Anja Schaich,Arnoud Arntz,Till Wagner,Philipp Herzog,Daniel Alvarez-Fischer,Valerija Sipos,Kamila Jauch-Chara,Jan Philipp Klein,Michael Hüppe,Ulrich Schweiger,Eva Fassbinder
INTRODUCTION In the treatment of borderline personality disorder (BPD), there is empirical support for both dialectical behavior therapy (DBT) and schema therapy (ST); these treatments have never been compared directly. This study examines whether either of them is more effective than the other in treating patients with BPD. METHODS In this randomized, parallel-group, rater-blind clinical trial, outpatients
-
Emotional Changes during Imagery Rescripting of Aversive Social Memories in Social Anxiety Disorder: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26 Rosa J Seinsche,Susanne Fricke,Marie K Neudert,Raphaela I Zimmer,Rudolf Stark,Andrea Hermann
INTRODUCTION Imagery rescripting (ImRs) is a psychotherapeutic intervention targeting aversive memories. During the three-phase intervention, patients reexperience their aversive memory (phase 1), observe the scene from their adult perspective, and intervene to help their former selves (phase 2), and reexperience it again with the positive changes (phase 3). Previous studies have rarely investigated
-
Prevalence and Rapid Screen Method of Diagnostic Criteria for Psychosomatic Research Syndromes in Human Papillomavirus-Infected Patients. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26 Xuelian Cui,Lixin Ding,Yongjuan Xu,Xiaosong Yuan,Qiaoli Zhang,Chiara Rafanelli,Sara Gostoli,Zhiwei Liu,Jianxin Cao
INTRODUCTION The early and rapid identification of psychosomatic symptoms is crucial to prevent harmful outcomes in patients with human papillomavirus (HPV) infection in busy comprehensive clinics. This study aimed to explore the prevalence and rapid screening method of the Diagnostic Criteria for Psychosomatic Research-revised (DCPR) syndromes in patients with HPV infection. METHODS A total of 504
-
The Future of Enhanced Psychotherapy: Towards Precision Psychotherapy. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-26 Stephan Zipfel,Wolfgang Lutz,Silvia Schneider,Elisabeth Schramm,Jaime Delgadillo,Katrin E Giel
-
Randomization Bias, Multi-Morbidity, and the Composite Clinical Score. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-18 Ralph I Horwitz,James B Baker,Arnab Ghatak,Mark R Cullen
-
The Role of Neurosciences in Clinical Interviewing. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-14 Stefano Pallanti
-
Appreciating the Limits and Opportunities of Meta-Analyses to Understand Complex Psychological Trajectories: Reply to da Silveira et al. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-06-05 Amelia J Scott,Ashleigh B Correa,Madelyne A Bisby,Blake F Dear
-
Treating Posttraumatic Stress Disorder: The Complexities of the Clinical Realm. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-05-20 Ulrich Schnyder
-
Enhanced Skills Training in Affective and Interpersonal Regulation versus Treatment as Usual for ICD-11 Complex PTSD: A Pilot Randomised Controlled Trial (The RESTORE Trial). Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-30 Thanos Karatzias,Mark Shevlin,Marylène Cloitre,Walter Busuttil,Katherine Graham,Laura Hendrikx,Philip Hyland,Natasha Biscoe,Dominic Murphy
INTRODUCTION Complex PTSD (CPTSD) is a relatively new condition in ICD-11. This pilot randomised controlled trial aimed to compare a four-module intervention developed to target all symptoms of ICD-11 CPTSD, namely Enhanced Skills in Affective and Interpersonal Regulation (ESTAIR) with treatment as usual (TAU). The purpose of the study was to assess feasibility, safety, acceptability, and preliminary
-
Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-30 Anna-Carlotta Zarski,Kiona K Weisel,Thomas Berger,Tobias Krieger,Michael P Schaub,Matthias Berking,Dennis Görlich,Corinna Jacobi,David D Ebert
INTRODUCTION Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms. OBJECTIVE This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive
-
Clinical Use of Staging in Psychiatry. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-18 Giovanni A Fava
-
Long-Term Effectiveness of Cognitive Behavioral Therapy in Routine Outpatient Care for Youth with Anxiety Disorders. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-12 Karen Krause,Xiao Chi Zhang,Silvia Schneider
INTRODUCTION This study examined the long-term effectiveness of cognitive behavioral therapy (CBT) (≥ 2 years after the end of therapy) in the routine care of youth (mean 11.95 years; SD = 3.04 years) with primary anxiety disorder (AD). METHODS Two hundred and ten children with any AD as a primary diagnosis and with any comorbidity were included in the "Kids Beating Anxiety (KibA)" clinical trial and
-
The Endeavor to Predict Depression and Anxiety Trajectories in the Context of Chronic Diseases Remains a Formidable Challenge. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-12 Pedro Lucas Santana da Silveira,Guilherme Nobre Nogueira,Marisa Bezerra de Araújo,Fabio Gomes de Matos E Souza,Luísa Weber Bisol
-
Indicated Stress Prevention Addressing Adolescents with High Stress Levels Based on Principles of Acceptance and Commitment Therapy: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-04-08 Franziska Binder,Julian Koenig,Franz Resch,Michael Kaess
INTRODUCTION Stress affects many adolescents and is associated with physical and mental health symptoms that can have a negative impact on normative development. However, there are very few evidence-based, specific treatment approaches. The aim of the study was to investigate an eight-session group intervention using components of Acceptance and Commitment Therapy (ACT) enriched with elements of CBT
-
The Impact of Online Health Information Seeking on Patients, Clinicians, and Patient-Clinician Relationship. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-26 Vladan Starcevic
-
Restoring and Preserving the Clinical Interview. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-15 Kurt Kroenke
-
Will Interviewing Become a Lost Art? Psychother. Psychosom. (IF 16.3) Pub Date : 2024-03-08 Steven L Dubovsky
-
Acceptance and Commitment Therapy, Combined with Bedtime Restriction, versus Cognitive Behavioral Therapy for Insomnia: A Randomized Controlled Pilot Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-02-28 Elisabeth Hertenstein,Ersilia Trinca,Carlotta L Schneider,Kristoffer D Fehér,Anna F Johann,Christoph Nissen
INTRODUCTION Cognitive behavioral therapy for insomnia (CBT-I) is the current first-line treatment for insomnia. However, rates of nonresponse and nonremission are high and effects on quality of life are only small to moderate, indicating a need for novel treatment developments. We propose that Acceptance and Commitment Therapy (ACT) addresses core pathophysiological pathways of insomnia. ACT therefore
-
Clinical Interviewing: An Essential but Neglected Method of Medicine. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-02-21 Giovanni A Fava,Nicoletta Sonino,David C Aron,Richard Balon,Carmen Berrocal Montiel,Jianxin Cao,John Concato,Ajandek Eory,Ralph I Horwitz,Chiara Rafanelli,Ulrich Schnyder,Hongxing Wang,Thomas N Wise,Jesse H Wright,Stephan Zipfel,Chiara Patierno
Clinical interviewing is the basic method to understand how a person feels and what are the presenting complaints, obtain medical history, evaluate personal attitudes and behavior related to health and disease, give the patient information about diagnosis, prognosis, and treatment, and establish a bond between patient and physician that is crucial for shared decision making and self-management. However
-
Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-29 Kerstin Blom,Erik Forsell,Monica Hellberg,Cecilia Svanborg,Susanna Jernelöv,Viktor Kaldo
INTRODUCTION Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for
-
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-25 Taeho Greg Rhee,Sung Ryul Shim,Kevin J Manning,Howard A Tennen,Tyler S Kaster,Giacomo d'Andrea,Brent P Forester,Andrew A Nierenberg,Roger S McIntyre,David C Steffens
INTRODUCTION Cognitive dysfunction or deficits are common in patients with major depressive disorder (MDD). The current study systematically reviews and meta-analyzes multiple domains of cognitive impairment in patients with MDD. METHODS PubMed/MEDLINE, PsycINFO, Cochrane Library, Embase, Web of Science, and Google Scholar were searched from inception through May 17, 2023, with no language limits.
-
One-Day Peer-Delivered Cognitive Behavioral Therapy-Based Workshops for Postpartum Depression: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-25 Zoryana Babiy,Haley Layton,Calan D Savoy,Feng Xie,June S L Brown,Peter J Bieling,David L Streiner,Mark A Ferro,Ryan J Van Lieshout
INTRODUCTION Myriad treatment barriers prevent birthing parents with postpartum depression (PPD) from receiving timely treatment. We aimed to determine whether a peer-delivered online 1-day cognitive behavioral therapy (CBT)-based workshop added to treatment as usual (TAU) improves PPD and its comorbidities and is more cost-effective than TAU alone. METHODS This parallel-group, randomized controlled
-
Mortality and Lithium-Protective Effects after First-Episode Mania Diagnosis in Bipolar Disorder: A Nationwide Retrospective Cohort Study in Taiwan. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-09 Andre F Carvalho,Chih-Wei Hsu,Eduard Vieta,Marco Solmi,Wolfgang Marx,Michael Berk,Chih-Sung Liang,Ping-Tao Tseng,Liang-Jen Wang
INTRODUCTION This study aimed to estimate all-cause mortality in patients after a first-episode mania (FEM) and examine whether six guideline-recommended medications can reduce mortality. METHODS The cohort included population-based FEM samples and matched controls from Taiwan, spanning 2007 to 2018. The primary outcomes assessed were all-cause/suicide-related mortality, while the secondary outcome
-
Rasch Analysis and Its Relevance to Psychosomatic Medicine. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-04 Kaj Sparle Christensen,Fiammetta Cosci,Danilo Carrozzino,Tom Sensky
-
Effectiveness of Schema Therapy versus Cognitive Behavioral Therapy versus Supportive Therapy for Depression in Inpatient and Day Clinic Settings: A Randomized Clinical Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-01-04 Johannes Kopf-Beck,Celina L Müller,Jeanette Tamm,Julia Fietz,Nils Rek,Leah Just,Zoe Ilona Spock,Katharina Weweck,Keisuke Takano,Martin Rein,Martin E Keck,Samy Egli
INTRODUCTION Schema therapy (ST) reduces depressive symptoms, but clinical trials have not investigated its effectiveness for patients suffering from severe forms of depression and high rates of comorbidities. There is high demand for exploring and improving treatments for this patient group. The objective of the current study was to evaluate whether ST is more effective than individual supportive
-
Longitudinal Clusters of Long-Term Trajectories in Patients with Early-Onset Chronic Depression: 2 Years of Naturalistic Follow-Up after Extensive Psychological Treatment. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-28 Moritz Elsaesser,Bernd Feige,Levente Kriston,Lea Schumacher,Jasmin Peifer,Martin Hautzinger,Martin Härter,Elisabeth Schramm
INTRODUCTION In clinical trials, mostly group-level treatment effects of repeated cross-sectional measures are analyzed. However, substantial heterogeneity regarding individual symptom profiles and the variability of treatment effects are often neglected, especially over the long-term course. To provide effective personalized treatments, investigations of these characteristics are urgently needed.
-
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-22 Carlos López-Pinar,Helena Rosen,Benjamin Selaskowski,Christian Staerk,Thomas Jans,Wolfgang Retz,Petra Retz-Junginger,Michael Roesler,Esther Sobanski,Michael Huss,Swantje Matthies,Ludger Tebartz van Elst,Mathias Berger,Christian Jacob,Bernhard Kis,Michael Colla,Barbara Alm,Mona Abdel-Hamid,Sonia Martínez-Sanchís,Enrique Carbonell-Vayá,Silke Lux,Alexandra Philipsen
INTRODUCTION Cognitive behavioral therapy and dialectical behavior therapy (DBT) can be effective in treating adults with ADHD, and patients generally consider these interventions useful. While adherence, as measured by attendance at sessions, is mostly sufficient, adherence to therapy skills has not been assessed. Furthermore, the relationship between patient evaluation of therapy effectiveness, treatment
-
Screening Second Victims for Emotional Distress: Assessment of the Clinimetric Properties of the WITHSTAND-PSY Questionnaire. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-20 Isolde Martina Busch,Maria Angela Mazzi,Loretta Berti,Albert W Wu,Fiammetta Cosci,Veronica Marinelli,Francesca Moretti,Michela Rimondini
INTRODUCTION Adverse events (AEs) are a leading cause of patient morbidity and mortality, greatly impacting healthcare providers' well-being (second victim (SV) phenomenon). Since it is not accurately captured by existing psychometric instruments, we developed a clinimetric instrument for assessing SVs' emotional distress before and after an AE. METHODS Content validity and clinical utility of the
-
The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-07 Guy Chouinard,Fiammetta Cosci,Virginie-Anne Chouinard,Larry Alphs
BACKGROUND The Extrapyramidal Symptom Rating Scale - Abbreviated (ESRS-A) is an abbreviated version of the Extrapyramidal Symptom Rating Scale (ESRS) with instructions, definitions, and a semi-structured interview that follows clinimetric concepts of measuring clinical symptoms. Similar to the ESRS, the ESRS-A was developed to assess four types of drug-induced movement disorders (DIMD): parkinsonism
-
The Use of Authorized Concealment to Minimize Nocebo Side Effects: A Survey of US Public Attitudes. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-01 Andrew L Geers,Emily K Spotts,Michael Vang,Samantha R Mayer,Franklin G Miller
INTRODUCTION To minimize nocebo effects, it may be possible to employ authorized concealment, in which clinicians tell patients about the nocebo phenomenon and ask if they would prefer not to be informed about mild treatment side effects. OBJECTIVE The objective of the study was to understand public evaluations of authorized concealment for reducing nocebo effects. METHODS An online cross-sectional
-
The Effects of Mindfulness for Youth (MYmind) versus Group Cognitive Behavioral Therapy in Improving Attention and Reducing Behavioral Problems among Children with Attention-Deficit Hyperactivity Disorder and Their Parents: A Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-12-01 Samuel Yeung Shan Wong,Stanley Kam Chung Chan,Benjamin Hon Kei Yip,Wenyue Wang,Herman Hay Ming Lo,Dexing Zhang,Susan M Bögels
INTRODUCTION There is a lack of studies evaluating mindfulness-based interventions for children with attention-deficit hyperactivity disorder (ADHD) compared with an evidence-based control. This randomized controlled trial (RCT) evaluated the effects of mindfulness for youth (MYmind) in improving children's attention, behavior, and parent-related outcomes versus cognitive behavioral therapy (CBT).
-
Precision Medicine and the Challenges of Human Complexity. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-17 David C Aron
-
Effects of a Web-Based Behavioral Activation Intervention on Depressive Symptoms, Activation, Motivation, and Volition: Results of a Randomized Controlled Trial. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-08 Claudia Mueller-Weinitschke,Jürgen Bengel,Harald Baumeister,Lena Violetta Krämer
INTRODUCTION Behavioral activation (BA) is effective for the treatment of depression. The Health Action Process Approach (HAPA), which is derived from health psychology, can provide a motivational-volitional framework of BA. OBJECTIVE This study investigated the efficacy of a HAPA-based internet-delivered BA intervention (iBA; called InterAKTIV) in individuals with depression, also assessing HAPA-based
-
Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder: A Randomized Clinical Trial (MBT-RCT). Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-07 Sophie Juul,Janus Christian Jakobsen,Emilie Hestbaek,Caroline Kamp Jørgensen,Markus Harboe Olsen,Marie Rishede,Frederik Weischer Frandsen,Sune Bo,Susanne Lunn,Stig Poulsen,Per Sørensen,Anthony Bateman,Sebastian Simonsen
INTRODUCTION Borderline personality disorder (BPD) is a severe and prevalent psychiatric disorder. Mentalization-based therapy (MBT) is an evidence-based intervention for BPD, and several countries offer treatment programs for BPD lasting for years, which is resource demanding. No previous trial has compared short-term with long-term MBT. OBJECTIVE The aim of the study was to assess the efficacy and
-
Allostatic Load and Allostatic Overload: Preventive and Clinical Implications. Psychother. Psychosom. (IF 16.3) Pub Date : 2023-11-06 Monique C Pfaltz,Ulrich Schnyder